-
1.HISTONE DEACETYLASE INHIBITORS AND COMPOSITIONS AND METHODS OF USE THEREOF 审中-公开
标题翻译: HISTON DEACETYLASE HEMMER及其组合物和使用它们的方法公开(公告)号:EP2968233A4
公开(公告)日:2016-08-03
申请号:EP14775793
申请日:2014-03-10
申请人: CHDI FOUNDATION INC
发明人: DOMINGUEZ CELIA , MUÑOZ-SAN JUAN IGNACIO , MAILLARD MICHEL , RAPHY GILLES , HAUGHAN ALAN F , LUCKHURST CHRISTOPHER A , JARVIS REBECCA E , BURLI ROLAND W , WISHART GRANT , HUGHES SAMANTHA J , ALLEN DANIEL R , PENROSE STEPHEN D , BRECCIA PERLA
IPC分类号: A61K31/16
CPC分类号: C07C233/60 , C07C259/08 , C07C2601/08 , C07C2601/14 , C07C2601/18 , C07D209/46 , C07D213/54 , C07D213/56 , C07D213/58 , C07D215/06 , C07D215/14 , C07D231/12 , C07D231/56 , C07D235/06 , C07D235/08 , C07D239/26 , C07D263/56 , C07D263/57 , C07D265/30 , C07D265/36 , C07D277/64 , C07D277/66 , C07D295/073 , C07D307/79 , C07D307/81 , C07D311/96 , C07D333/54 , C07D401/12 , C07D413/06 , C07D471/04
-
公开(公告)号:EP3148539A4
公开(公告)日:2018-01-03
申请号:EP15803976
申请日:2015-06-01
申请人: CHDI FOUNDATION INC
发明人: DOMINGUEZ CELIA , MUN OZ-SANJUAN IGNACIO , LUCKHURST CHRISTOPHER A , ALLEN DANIEL R , RAPHY GILLES , BÛRLI ROLAND W , BRECCIA PERLA , HAUGHAN ALAN F , WISHART GRANT , HUGHES SAMANTHA J , JARVIS REBECCA E , VATER HUW D , PENROSE STEPHEN D , WALL MICHAEL , STOTT ANDREW J , SAVILLE-STONES ELIZABETH
IPC分类号: C07D231/54 , A61K31/423 , A61K31/4245 , A61K31/4709 , A61P25/28 , C07D275/04 , C07D277/60 , C07D401/04 , C07D403/04 , C07D417/04
CPC分类号: C07D417/04 , C07C259/08 , C07D231/54 , C07D231/56 , C07D239/70 , C07D239/74 , C07D239/88 , C07D275/04 , C07D277/60 , C07D401/04 , C07D403/04
摘要: Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, or pharmaceutically acceptable salts thereof, compositions thereof, and methods of their use. The condition or disorder mediated by HDAC comprises a neurodegenerative pathology. Accordingly, also provided is a method of treating a neurodegenerative pathology mediated by HDAC in a subject in need of such a treatment, comprising administering to the subject a therapeutically effective amount of at least one compound, or pharmaceutically acceptable salt thereof, described herein.
-
公开(公告)号:EP2968207A4
公开(公告)日:2016-09-28
申请号:EP14775535
申请日:2014-03-10
申请人: CHDI FOUNDATION INC
发明人: DOMINGUEZ CELIA , MUÑOZ-SANJUAN IGNACIO , MAILLARD MICHEL , LUCKHURST CHRISTOPHER A , JARVIS REBECCA E , BÜRLI ROLAND W , ALLEN DANIEL R , HAUGHAN ALAN F , BRECCIA PERLA , VATER HUW D , STOTT ANDREW J , PENROSE STEPHEN D , WALL MICHAEL , SAVILLE-STONES ELIZABETH A , WISHART GRANT , HUGHES SAMANTHA J
IPC分类号: C07D231/12 , A61K31/015 , A61K31/02 , A61K31/166 , C07C259/08 , C07D213/56 , C07D213/61 , C07D213/64 , C07D231/56 , C07D239/26 , C07D241/12 , C07D241/42 , C07D261/20 , C07D275/04 , C07D277/62 , C07D277/64 , C07D333/60 , C07D471/04
CPC分类号: C07D471/04 , C07C259/08 , C07C2601/02 , C07C2601/10 , C07D213/56 , C07D213/61 , C07D213/64 , C07D231/12 , C07D231/56 , C07D239/26 , C07D241/12 , C07D241/42 , C07D261/20 , C07D275/04 , C07D277/62 , C07D277/64 , C07D333/60
摘要: Provided are certain histone deacetylase (HDAC) inhibitors of Formula I, compositions thereof, and methods of their use.
-
-